Yale University
The purpose of this study is to evaluate whether an Integrated Digital Health (IDH) intervention with and without healthcare provider engagement, improves glycemic control and diabetes-related outcomes among adults with Type 2 diabetes. The study will also assess the feasibility of integrating this approach into routine primary care to support personalized, data-informed diabetes management.
Participants will complete a total of three study visits: a baseline visit (which includes consent, screening, and enrollment procedures), a 16-week follow-up visit, and a 32-week follow-up visit. Each study visit is expected to last approximately 30 minutes. In addition, participants will complete study surveys throughout the study period, which are expected to require approximately 30-40 minutes per survey. Depending on study group assignment, participants may also use study devices and mobile applications to track health behaviors and/or participate in telehealth visits with a healthcare pr…
Inclusion Criteria: * diagnosis of T2D for at least one year * recent 3 month-HbA1c, 8-11% * ownership of a smartphone * English or Spanish speaking. Exclusion Criteria: * pregnant * not available or willing to use CGM or study device/platform * serious medical conditions or active thought disorders (e.g., terminal cancer, schizophrenia) In addition to the self-report of the HbA1c within the past 3 months, potential participants will be screened with a point-of-care (POC) HbA1c (A1CNow®+).
CGM, wearable for physical activity and sleep, food scan/log
Weekly feedback through the IDH platform plus monthly video calls
Arctuva estimate
Verify or correct the compensation shown for this listing.